| abstract |
Described herein are compounds and pharmaceutical compositions comprising such compounds that inhibit the activity of histone deacetylase 8 (HDAC8). Also described herein are methods of using such HDAC8 inhibitors, alone or in combination with other compounds, for the treatment of diseases or conditions that would benefit from inhibition of HDAC8 activity. The [Selection figure] None |